NEW YORK, June 19 /PRNewswire/ -- The following is being issued by M.R. Beal & Company, a member of the National Association of Securities Dealers,
CRD number 22088:
Michael Heffernan, an eHealthcare analyst at M. R. Beal & Company (CRD# 22088) initiated coverage of Ventro Corporation (Nasdaq: VNTR) this morning with
a Buy recommendation and a 12-month target price of $60 per share.
In a one-page note, Heffernan describes Ventro as a leading builder of vertical marketplace companies in the world of online Business-to-Business eCommerce.
Currently, Ventro operates its online procurement solution in five vertical markets including: Life Sciences, Hospital & Medical Supplies, Specialty Medical
Products, Industrial Fluid Processing and Institutional Food Service, and has partnered with several industry leaders such as Dupont, IBM, Tenet Healthcare
Corporation, and VWR Scientific Products. |
